Literature DB >> 7807023

CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE.

R Paganelli1, E Scala, I J Ansotegui, C M Ausiello, E Halapi, E Fanales-Belasio, G D'Offizi, I Mezzaroma, F Pandolfi, M Fiorilli, A Cassone, F Aiuti.   

Abstract

Increased levels of serum IgE and eosinophilia have been described in human immunodeficiency virus (HIV) infection, almost exclusively in patients with CD4+ cell count < 200 cells/microliters. IgE production is regulated by CD4+ T helper type 2 (Th-2) lymphocytes, producing interleukin 4 (IL-4) and expressing a ligand for the B cell-specific CD40 molecule (CD40 ligand [L]). A shift to a Th-2-like pattern of cytokine secretion has been postulated to be associated with progression toward acquired immunodeficiency syndrome (AIDS). We studied three AIDS patients with very high levels of IgE and almost complete depletion of CD4+ lymphocytes, suggesting that IgE synthesis could not be driven by CD4+ cells. IgE in vitro synthesis by cells from such patients was, however, inhibited by anti-IL-4. We show that both CD8+ T cell lines and the majority of CD8+ T cells clones derived from these patients produce IL-4, IL-5, and IL-6 in half of the cases together with interferon gamma (IFN-gamma). 44% of CD8+ T cell clones expressed a CD40L, and the supernatants of the clones were capable of inducing IgE synthesis by normal B cells costimulated with anti-CD40. CD8+ T cells in these patients therefore functionally mimic Th-2 type cells and may account for hyper-IgE and eosinophilia in the absence of CD4+ cells. The presence of such CD8+ cells may also provide a source of IL-4 directing the development of predominant Th-2 responses in HIV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7807023      PMCID: PMC2191846          DOI: 10.1084/jem.181.1.423

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Serum IgE levels in 622 persons with human immunodeficiency virus infection: IgE elevation with marked depletion of CD4+ T-cells.

Authors:  D R Lucey; R A Zajac; G P Melcher; C A Butzin; R N Boswell
Journal:  AIDS Res Hum Retroviruses       Date:  1990-04       Impact factor: 2.205

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones.

Authors:  X Paliard; R de Waal Malefijt; H Yssel; D Blanchard; I Chrétien; J Abrams; J de Vries; H Spits
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

5.  Defective in vitro production of gamma-interferon and tumor necrosis factor-alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome.

Authors:  G Del Prete; A Tiri; E Maggi; M De Carli; D Macchia; P Parronchi; M E Rossi; M C Pietrogrande; M Ricci; S Romagnani
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

6.  Allergic manifestations of human immunodeficiency virus (HIV) infection.

Authors:  A Carr; D A Cooper; R Penny
Journal:  J Clin Immunol       Date:  1991-03       Impact factor: 8.317

Review 7.  Hyper immunoglobulin E syndrome.

Authors:  R S Geha; D Y Leung
Journal:  Immunodefic Rev       Date:  1989

8.  Frequent coexpression of cytolytic activity and lymphokine production among human T lymphocytes. Production of B cell growth factor and interleukin 2 by T8+ and T4+ cytolytic clones.

Authors:  M C Mingari; A Moretta; E Maggi; G Pantaleo; F Gerosa; S Romagnani; L Moretta
Journal:  Eur J Immunol       Date:  1984-11       Impact factor: 5.532

9.  Serum IgE and human immunodeficiency virus (HIV) infection.

Authors:  D N Wright; R P Nelson; D K Ledford; E Fernandez-Caldas; W L Trudeau; R F Lockey
Journal:  J Allergy Clin Immunol       Date:  1990-02       Impact factor: 10.793

10.  Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory.

Authors:  S Ehlers; K A Smith
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  19 in total

1.  Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry.

Authors:  K Bendelja; A Gagro; A Bace; R Lokar-Kolbas; V Krsulovic-Hresic; V Drazenovic; G Mlinaric-Galinovic; S Rabatic
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Role of IgE immune complexes in the regulation of HIV-1 replication and increased cell death of infected U1 monocytes: involvement of CD23/Fc epsilon RII-mediated nitric oxide and cyclic AMP pathways.

Authors:  F Ouaaz; F W Ruscetti; B Dugas; J Mikovits; H Agut; P Debré; M D Mossalayi
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

3.  Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression.

Authors:  A Valentin; W Lu; M Rosati; R Schneider; J Albert; A Karlsson; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

Review 4.  Immune dysregulation and CD4+ T cell loss in HIV-1 infection.

Authors:  L Meyaard; F Miedema
Journal:  Springer Semin Immunopathol       Date:  1997

5.  CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines.

Authors:  R S Kornbluth; K Kee; D D Richman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

Review 6.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

7.  T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.

Authors:  P Rizza; S M Santini; M A Logozzi; C Lapenta; P Sestili; G Gherardi; R Lande; M Spada; S Parlato; F Belardelli; S Fais
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12.

Authors:  A Blauvelt; C Chougnet; G M Shearer; S I Katz
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

9.  Human T cells with a type-2 cytokine profile are resistant to apoptosis induced by primary activation: consequences for immunopathogenesis.

Authors:  M Carbonari; T Tedesco; P Del Porto; R Paganelli; M Fiorilli
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

10.  CD40-Mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir.

Authors:  S Moir; R Lapointe; A Malaspina; M Ostrowski; C E Cole; T W Chun; J Adelsberger; M Baseler; P Hwu; A S Fauci
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.